In 2021, with the COVID-19 pandemic in full swing, BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) were the darlings of the pharma and biotech worlds. The two mRNA therapy developers created COVID ...

STONY BROOK, NY / ACCESSWIRE / November 9, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it has ...

Even after a promising experiment sparked expectations for the potential of messenger RNA (mRNA) vaccines, one of the field's early proponents now warns that the treatments have limitations when it ...

A chance meeting at a photocopier. The promise of a safer way to vaccinate. Unexpected calamities in the lab. Finally, a breakthrough and a major publication, only to be met with … crickets. That is, ...

The incredible success of the two mRNA vaccines against COVID-19 sparked a surge of interest and investment in this new therapeutic modality. And because mRNA is infinitely programmable, scientists ...

WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently ...